{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:16:12Z","timestamp":1788383772893,"version":"build-2803163510"},"reference-count":189,"publisher":"American Society of Parasitologists","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Parasitology"],"published-print":{"date-parts":[[2021,11,30]]},"DOI":"10.1645\/20-157","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:58:05Z","timestamp":1638295085000},"source":"Crossref","is-referenced-by-count":16,"title":["Review of DNA Vaccine Approaches Against the Parasite Toxoplasma gondii"],"prefix":"10.1645","volume":"107","author":[{"given":"Rosalie C.","family":"Warner","sequence":"first","affiliation":[{"name":"Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, 68182"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, 68182"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna N.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, 68182"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, 68182"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1220","reference":[{"key":"102","doi-asserted-by":"crossref","unstructured":"G. A. Mcconkey, H. L. Martin, G. C. Bristow, et al. \"Journal of Experimental Biology.\" 216, \"Toxoplasma gondii infection and behaviour\u2014Location, location, location?\" 113 (2013)","DOI":"10.1242\/jeb.074153"},{"key":"30","doi-asserted-by":"crossref","unstructured":"X. Cui, T. Lei, D. Yang, et al. \"Vaccine.\" 30, \"Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.\" 2282 (2012)","DOI":"10.1016\/j.vaccine.2012.01.073"},{"key":"95","doi-asserted-by":"crossref","unstructured":"G. Lu, L. Wang, A. Zhou, et al. \"Acta Tropica.\" 146, \"Epitope analysis, expression and protection of SAG5A vaccine against Toxoplasma gondii.\" 66 (2015)","DOI":"10.1016\/j.actatropica.2015.03.013"},{"key":"132","doi-asserted-by":"crossref","unstructured":"P. Sonaimuthu, X. T. Ching, M. Y. Fong, et al. \"Frontiers in Microbiology.\" 7, \"Induction of protective immunity against toxoplasmosis in BALB\/c mice vaccinated with Toxoplasma gondii Rhoptry-1.\" 808 (2016)","DOI":"10.3389\/fmicb.2016.00808"},{"key":"133","doi-asserted-by":"crossref","unstructured":"P. Song, S. He, A. Zhou, et al. \"BMC Infectious Diseases.\" 17, \"Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.\" 19 (2017)","DOI":"10.1186\/s12879-016-2147-1"},{"key":"1","doi-asserted-by":"crossref","unstructured":"E. Ahmadpour, S. Sarvi, M. B. Hashemi Soteh, et al. \"Parasite Immunology.\" 39, \"Evaluation of the immune response in BALB\/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii.\" e12419 (2017a)","DOI":"10.1111\/pim.12419"},{"key":"2","doi-asserted-by":"crossref","unstructured":"E. Ahmadpour, S. Sarvi, M. B. Hashemi Soteh, et al. \"Immunology Letters.\" 185, \"Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by calcium phosphate nanoparticles as an adjuvant.\" 40 (2017b)","DOI":"10.1016\/j.imlet.2017.03.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"P. H. Alday and J. S. Doggett \"Drug Design, Development and Therapy.\" 11, \"Drugs in development for toxoplasmosis: Advances, challenges, and current status.\" 273 (2017)","DOI":"10.2147\/DDDT.S60973"},{"key":"4","doi-asserted-by":"crossref","unstructured":"P. Alizadeh, E. Ahmadpour, A. Daryani, et al. \"Journal of Cellular Physiology.\" 234, \"IL-17 and IL-22 elicited by a DNA vaccine encoding ROP13 associated with protection against Toxoplasma gondii in BALB\/c mice.\" 10782 (2019)","DOI":"10.1002\/jcp.27747"},{"key":"5","doi-asserted-by":"crossref","unstructured":"M. Z. K. Assir, H. I. Ahmad, J. Akram, et al. \"Basic & Clinical Pharmacology & Toxicology.\" 115, \"An outbreak of pyrimethamine toxicity in patients with ischaemic heart disease in Pakistan.\" 291 (2014)","DOI":"10.1111\/bcpt.12206"},{"key":"6","doi-asserted-by":"crossref","unstructured":"J. P. Assolini, V. M. Concato, M. D. Gon\u00e7alves, et al. \"Parasitology Research.\" 116, \"Nanomedicine advances in toxoplasmosis: Diagnostic, treatment, and vaccine applications.\" 1603 (2017)","DOI":"10.1007\/s00436-017-5458-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"L. A. Babiuk, R. Pontarollo, S. Babiuk, et al. \"Vaccine.\" 21, \"Induction of immune responses by DNA vaccines in large animals.\" 649 (2003)","DOI":"10.1016\/S0264-410X(02)00574-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"C. Beauvillain, M. O. Juste, S. Dion, et al. \"Vaccine.\" 27, \"Exosomes are an effective vaccine against congenital toxoplasmosis in mice.\" 1750 (2009)","DOI":"10.1016\/j.vaccine.2009.01.022"},{"key":"9","doi-asserted-by":"crossref","unstructured":"M. Bivas-Benita, M. Laloup, S. Versteyhe, et al. \"International Journal of Pharmaceutics.\" 266, \"Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: Preparation, characterization, and preliminary in vivo studies.\" 17 (2003)","DOI":"10.1016\/S0378-5173(03)00377-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"M. W. Black and J. C. Boothroyd \"Microbiology and Molecular Biology Reviews.\" 64, \"Lytic cycle of Toxoplasma gondii.\" 607 (2000)","DOI":"10.1128\/MMBR.64.3.607-623.2000"},{"key":"11","doi-asserted-by":"crossref","unstructured":"N. Blanchard, F. Gonzalez, M. Schaeffer, et al. \"Nature Immunology.\" 9, \"Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum.\" 937 (2008)","DOI":"10.1038\/ni.1629"},{"key":"12","doi-asserted-by":"crossref","unstructured":"A. Bougdour, I. Tardieux, M.-A. Hakimi, \"Cellular Microbiology.\" 16, \"Toxoplasma exports dense granule proteins beyond the vacuole to the host cell nucleus and rewires the host genome expression.\" 334 (2014)","DOI":"10.1111\/cmi.12255"},{"key":"13","doi-asserted-by":"crossref","unstructured":"A. Burrells, J. Benavides, G. Cant\u00f3n, et al. \"Veterinary Research.\" 46, \"Vaccination of pigs with the S48 strain of Toxoplasma gondii\u2014Safer meat for human consumption.\" 47 (2015)","DOI":"10.1186\/s13567-015-0177-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"A. Cao, Y. Liu, J. Wang, et al. \"Vaccine.\" 33, \"Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.\" 6757 (2015)","DOI":"10.1016\/j.vaccine.2015.10.077"},{"key":"15","unstructured":"G. Chen, H. Chen, H. Guo, et al. \"Chinese Medical Journal.\" 115, \"Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.\" 1448 (2002)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"J. Chen, S.-Y. Huang, Z.-Y. Li, et al. \"Vaccine.\" 31, \"Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.\" 1734 (2013a)","DOI":"10.1016\/j.vaccine.2013.01.027"},{"key":"17","doi-asserted-by":"crossref","unstructured":"J. Chen, S.-Y. Huang, D.-H. Zhou, et al. \"Vaccine.\" 31, \"DNA immunization with eukaryotic initiation factor-2\u03b1 of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.\" 6225 (2013b)","DOI":"10.1016\/j.vaccine.2013.10.034"},{"key":"18","doi-asserted-by":"crossref","unstructured":"J. Chen, Z.-Y. Li, S.-Y. Huang, et al. \"BMC Infectious Diseases.\" 14, \"Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice.\" 487 (2014a)","DOI":"10.1186\/1471-2334-14-487"},{"key":"19","doi-asserted-by":"crossref","unstructured":"J. Chen, Z.-Y. Li, E. Petersen, et al. \"Experimental Parasitology.\" 162, \"Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.\" 18 (2016)","DOI":"10.1016\/j.exppara.2015.12.013"},{"key":"20","doi-asserted-by":"crossref","unstructured":"J. Chen, D.-H. Zhou, Z.-Y. Li, et al. \"Experimental Parasitology.\" 139, \"Toxoplasma gondii: Protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.\" 42 (2014b)","DOI":"10.1016\/j.exppara.2014.02.016"},{"key":"21","doi-asserted-by":"crossref","unstructured":"K. Chen, J.-L. Wang, S.-Y. Huang, et al. \"Parasite.\" 24, \"Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2).\" 41 (2017)","DOI":"10.1051\/parasite\/2017045"},{"key":"22","doi-asserted-by":"crossref","unstructured":"R. Chen, S.-H. Lu, Q.-B. Tong, et al. \"Journal of Zhejiang University. Science. B.\" 10, \"Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii.\" 512 (2009)","DOI":"10.1631\/jzus.B0820300"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Y. Chen, M. Yu, J. A. Hemandez, et al. \"Experimental Parasitology.\" 188, \"Immuno-efficacy of DNA vaccines encoding PLP1 and ROP18 against experimental Toxoplasma gondii infection in mice.\" 73 (2018)","DOI":"10.1016\/j.exppara.2018.04.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"X. T. Ching, M. Y. Fong, Y. L. Lau, \"American Journal of Tropical Medicine and Hygiene.\" 96, \"Evaluation of the protective effect of deoxyribonucleic acid vaccines encoding granule antigen 2 and 5 against acute toxoplasmosis in BALB\/c Mice.\" 1441 (2017)","DOI":"10.4269\/ajtmh.16-0548"},{"key":"25","doi-asserted-by":"crossref","unstructured":"J.-Q. Chu, S. Huang, W. Ye, et al. \"Korean Journal of Parasitology.\" 56, \"Evaluation of protective immune response induced by a DNA vaccine encoding GRA8 against acute toxoplasmosis in a murine model.\" 325 (2018)","DOI":"10.3347\/kjp.2018.56.4.325"},{"key":"26","doi-asserted-by":"crossref","unstructured":"H. Cong, Q.-M. Gu, H. E. Yin, et al. \"Vaccine.\" 26, \"Multi-epitope DNA vaccine linked to the A2\/B subunit of cholera toxin protect mice against Toxoplasma gondii.\" 3913 (2008)","DOI":"10.1016\/j.vaccine.2008.04.046"},{"key":"27","unstructured":"H. Cong, Q.-M. Gu, H.-Y. Zhou, et al. \"Chinese Journal of Parasitology & Parasitic Diseases.\" 23, \"Oral mixed DNA vaccine protects mice from infection of Toxoplasma gondii].\" 159 (2005)"},{"key":"28","doi-asserted-by":"crossref","unstructured":"H. Cong, Q. Yuan, Q. Zhao, et al. \"Parasites & Vectors.\" 7, \"Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice.\" 145 (2014)","DOI":"10.1186\/1756-3305-7-145"},{"key":"29","doi-asserted-by":"crossref","unstructured":"K. N. Couper, H. V. Nielsen, E. Petersen, et al. \"Vaccine.\" 21, \"DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission.\" 2813 (2003)","DOI":"10.1016\/S0264-410X(03)00163-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Y.-L. Cui, S.-Y. He, M.-F. Xue, et al. \"Parasite Immunology.\" 30, \"Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice.\" 309 (2008)","DOI":"10.1111\/j.1365-3024.2008.01025.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"P. Czarnewski, E. C. B. Ara\u00fajo, M. C. Oliveira, et al. \"Frontiers in Cellular and Infection Microbiology.\" 7, \"Recombinant TgHSP70 immunization protects against Toxoplasma gondii brain cyst formation by enhancing inducible nitric oxide expression.\" 142 (2017)","DOI":"10.3389\/fcimb.2017.00142"},{"key":"33","doi-asserted-by":"crossref","unstructured":"G. Dautu, B. Munyaka, G. Carmen, et al. \"Experimental Parasitology.\" 116, \"Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.\" 273 (2007)","DOI":"10.1016\/j.exppara.2007.01.017"},{"key":"34","doi-asserted-by":"crossref","unstructured":"M. Demar, D. Ajzenberg, D. Maubon, et al. \"Clinical Infectious Diseases.\" 45, \"Fatal outbreak of human toxoplasmosis along the Maroni River: Epidemiological, clinical, and parasitological aspects.\" e88 (2007)","DOI":"10.1086\/521246"},{"key":"35","doi-asserted-by":"crossref","unstructured":"E. Dumonteil, \"Journal of Biomedicine and Biotechnology.\" 2007, \"DNA Vaccines against protozoan parasites: Advances and challenges.\" e90520 (2007)","DOI":"10.1155\/2007\/90520"},{"key":"36","doi-asserted-by":"crossref","unstructured":"I. R. Dunay, K. Gajurel, R. Dhakal, et al. \"Clinical Microbiology Reviews.\" 31, \"Treatment of toxoplasmosis: Historical perspective, animal models, and current clinical practice.\" e00057 (2018)","DOI":"10.1128\/CMR.00057-17"},{"key":"37","doi-asserted-by":"crossref","unstructured":"R. D. Etheridge, A. Alaganan, K. Tang, et al. \"Cell Host & Microbe.\" 15, \"The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice.\" 537 (2014)","DOI":"10.1016\/j.chom.2014.04.002"},{"key":"38","doi-asserted-by":"crossref","unstructured":"A. Fachado, A. Rodriguez, S. O. Angel, et al. \"Vaccine.\" 21, \"Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice.\" 1327 (2003)","DOI":"10.1016\/S0264-410X(02)00692-8"},{"key":"39","doi-asserted-by":"crossref","unstructured":"R. Fang, H. Feng, H. Nie, et al. \"Vaccine.\" 28, \"Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB\/c mice model.\" 1803 (2010)","DOI":"10.1016\/j.vaccine.2009.12.005"},{"key":"40","doi-asserted-by":"crossref","unstructured":"R. Fang, H. Nie, Z. Wang, et al. \"Veterinary Parasitology.\" 164, \"Protective immune response in BALB\/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii.\" 134 (2009)","DOI":"10.1016\/j.vetpar.2009.06.012"},{"key":"41","doi-asserted-by":"crossref","unstructured":"M. Foroutan, M. Barati, F. Ghaffarifar, \"Microbial Pathogenesis.\" 147, \"Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB\/ c mice.\" 104435 (2020a)","DOI":"10.1016\/j.micpath.2020.104435"},{"key":"42","doi-asserted-by":"crossref","unstructured":"M. Foroutan, F. Ghaffarifar, Z. Sharifi, et al. \"Comparative Immunology, Microbiology and Infectious Diseases.\" 69, \"Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice.\" 101413 (2020b)","DOI":"10.1016\/j.cimid.2020.101413"},{"key":"43","doi-asserted-by":"crossref","unstructured":"M. Foroutan, L. Zaki, F. Ghaffarifar, \"Clinical and Experimental Vaccine Research.\" 7, \"Recent progress in microneme-based vaccines development against Toxoplasma gondii.\" 93 (2018)","DOI":"10.7774\/cevr.2018.7.2.93"},{"key":"44","unstructured":"M. Foroutan, L. Zaki, S. Tavakoli, et al. \"EXCLI Journal.\" 18, \"Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii.\" 259 (2019)"},{"key":"45","doi-asserted-by":"crossref","unstructured":"N. Friedrich, J. M. Santos, Y. Liu, et al. \"Journal of Biological Chemistry.\" 285, \"Members of a novel protein family containing microneme adhesive repeat domains act as sialic acid-binding lectins during host cell invasion by apicomplexan parasites.\" 2064 (2010)","DOI":"10.1074\/jbc.M109.060988"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Q. Gao, N.-Z. Zhang, F.-K. Zhang, et al. \"BMC Infectious Diseases.\" 18, \"Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.\" 117 (2018)","DOI":"10.1186\/s12879-018-3022-z"},{"key":"47","doi-asserted-by":"crossref","unstructured":"F. Ghaffarifar, \"Reviews in Medical Microbiology.\" 26, \"Strategies of DNA vaccines against toxoplasmosis.\" 88 (2015)","DOI":"10.1097\/MRM.0000000000000037"},{"key":"48","unstructured":"F. Ghaffarifar, M. Jafarimodrek, H. Vazini, et al. \"Iranian Journal of Basic Medical Sciences.\" 22, \"Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB\/c mice.\" 901 (2019)"},{"key":"49","doi-asserted-by":"crossref","unstructured":"D. A. Gold, A. D. Kaplan, A. Lis, et al. \"Cell Host & Microbe.\" 17, \"The Toxoplasma dense granule proteins GRA17 and GRA23 mediate the movement of small molecules between the host and the parasitophorous vacuole.\" 642 (2015)","DOI":"10.1016\/j.chom.2015.04.003"},{"key":"50","doi-asserted-by":"crossref","unstructured":"P. Gong, L. Cao, Y. Guo, et al. \"Experimental Parasitology.\" 166, \"Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB\/c mice.\" 131 (2016)","DOI":"10.1016\/j.exppara.2016.04.003"},{"key":"51","doi-asserted-by":"crossref","unstructured":"P. Gong, X. Huang, Q. Yu, et al. \"Parasite Immunology.\" 35, \"The protective effect of a DNA vaccine encoding the Toxoplasma gondii cyclophilin gene in BALB\/c mice.\" 140 (2013)","DOI":"10.1111\/pim.12024"},{"key":"52","doi-asserted-by":"crossref","unstructured":"H.-T. Guo, Z.-Y. Li, J.-L. Wang, et al. \"Iranian Journal of Parasitology.\" 14, \"Immune responses induced by pVAX\/TgERK7 against Toxoplasma gondii infection in BALB\/c mice.\" 552 (2019)","DOI":"10.18502\/ijpa.v14i4.2097"},{"key":"53","doi-asserted-by":"crossref","unstructured":"H. E. Hajj, M. Lebrun, M. N. Fourmaux, et al. \"Cellular Microbiology.\" 9, \"Inverted topology of the Toxoplasma gondii ROP5 rhoptry protein provides new insights into the association of the ROP2 protein family with the parasitophorous vacuole membrane.\" 54 (2007)","DOI":"10.1111\/j.1462-5822.2006.00767.x"},{"key":"54","doi-asserted-by":"crossref","unstructured":"S. H\u00e5kansson, A. J. Charron, L. D. Sibley, \"EMBO Journal.\" 20, \"Toxoplasma evacuoles: A two-step process of secretion and fusion forms the parasitophorous vacuole.\" 3132 (2001)","DOI":"10.1093\/emboj\/20.12.3132"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Y. Han, A. Zhou, G. Lu, et al. \"Korean Journal of Parasitology.\" 55, \"DNA vaccines encoding Toxoplasma gondii cathepsin C 1 induce protection against toxoplasmosis in mice.\" 505 (2017a)","DOI":"10.3347\/kjp.2017.55.5.505"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Y. Han, A. Zhou, G. Lu, et al. \"BMC Infectious Diseases.\" 17, \"Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB\/c mice.\" 59 (2017b)","DOI":"10.1186\/s12879-016-2104-z"},{"key":"57","doi-asserted-by":"crossref","unstructured":"I. A. Hassan, S. Wang, L. Xu, et al. \"Parasites & Vectors.\" 7, \"DNA vaccination with a gene encoding Toxoplasma gondii deoxyribose phosphate aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice.\" 431 (2014a)","DOI":"10.1186\/1756-3305-7-431"},{"key":"58","doi-asserted-by":"crossref","unstructured":"I. A. Hassan, S. Wang, L. Xu, et al. \"Experimental Parasitology.\" 146, \"Immunoglobulin and cytokine changes induced following immunization with a DNA vaccine encoding Toxoplasma gondii selenium-dependent glutathione reductase protein.\" 1 (2014b)","DOI":"10.1016\/j.exppara.2014.08.011"},{"key":"59","doi-asserted-by":"crossref","unstructured":"I. A. Hassan, S. Wang, L. Xu, et al. \"Parasite Immunology.\" 36, \"Immunological response and protection of mice immunized with plasmid encoding Toxoplasma gondii glycolytic enzyme malate dehydrogenase.\" 674 (2014c)","DOI":"10.1111\/pim.12146"},{"key":"60","doi-asserted-by":"crossref","unstructured":"E. Hiszczyn\u0144ska-Sawicka, H. Li, Xu Boyu, et al. \"Polish Journal of Veterinary Sciences.\" 15, \"Induction of immune responses in sheep by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii MIC3 gene.\" 3 (2012)","DOI":"10.2478\/v10181-011-0107-7"},{"key":"61","doi-asserted-by":"crossref","unstructured":"E. Hiszczyn\u0144ska-Sawicka, H. Li, Xu Boyu, et al. \"Veterinary Parasitology.\" 183, \"Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154.\" 72 (2011a)","DOI":"10.1016\/j.vetpar.2011.06.010"},{"key":"62","doi-asserted-by":"crossref","unstructured":"E. Hiszczyn\u0144ska-Sawicka, H. Li, Xu Boyu, et al. \"Experimental Parasitology.\" 124, \"Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations.\" 365 (2010)","DOI":"10.1016\/j.exppara.2009.11.015"},{"key":"63","doi-asserted-by":"crossref","unstructured":"E. Hiszczyn\u0144ska-Sawicka, G. Oledzka, L. Holec-Gasior, et al. \"Veterinary Parasitology.\" 177, \"Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii.\" 281 (2011b)","DOI":"10.1016\/j.vetpar.2010.11.047"},{"key":"64","doi-asserted-by":"crossref","unstructured":"D. Hobernik and M. Bros \"International Journal of Molecular Sciences.\" 19, \"DNA Vaccines\u2014How far from clinical use?\" 3605 (2018)","DOI":"10.3390\/ijms19113605"},{"key":"65","doi-asserted-by":"crossref","unstructured":"S. Hoffmann, M. B. Batz, J. G. Morris, \"Journal of Food Protection.\" 75, \"Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens.\" 1292 (2012)","DOI":"10.4315\/0362-028X.JFP-11-417"},{"key":"66","doi-asserted-by":"crossref","unstructured":"K. Hoseinian Khosroshahi, F. Ghaffarifar, S. D'souza, et al. \"Vaccine.\" 29, \"Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis.\" 778 (2011)","DOI":"10.1016\/j.vaccine.2010.11.012"},{"key":"67","doi-asserted-by":"crossref","unstructured":"L.-Y. Hu, N.-Z. Zhang, F.-K. Zhang, et al. \"BioMed Research International.\" 2017, \"Resistance to chronic Toxoplasma gondii infection induced by a DNA vaccine expressing GRA16.\" 1295038 (2017)","DOI":"10.1155\/2017\/1295038"},{"key":"68","doi-asserted-by":"crossref","unstructured":"S.-Y. Huang, K. Chen, J.-L. Wang, et al. \"Microbial Pathogenesis.\" 133, \"Evaluation of protective immunity induced by recombinant calcium-dependent protein kinase 1 (TgCDPK1) protein against acute toxoplasmosis in mice.\" 103560 (2019)","DOI":"10.1016\/j.micpath.2019.103560"},{"key":"69","doi-asserted-by":"crossref","unstructured":"E. A. Innes, C. Hamilton, J. L. Garcia, et al. \"Food and Waterborne Parasitology.\" 15, \"A one health approach to vaccines against Toxoplasma gondii.\" e00053 (2019)","DOI":"10.1016\/j.fawpar.2019.e00053"},{"key":"70","doi-asserted-by":"crossref","unstructured":"A. B. Ismael, D. Hedhli, O. C\u00e9r\u00e8de, et al. \"Vaccine.\" 27, \"Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection.\" 2959 (2009)","DOI":"10.1016\/j.vaccine.2009.02.107"},{"key":"71","doi-asserted-by":"crossref","unstructured":"A. B. Ismael, D. Sekkai, C. Collin, et al. \"Infection and Immunity.\" 71, \"The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis.\" 6222 (2003)","DOI":"10.1128\/IAI.71.11.6222-6228.2003"},{"key":"72","doi-asserted-by":"crossref","unstructured":"E. Jongert, S. D. Craeye, J. Dewit, et al. \"Parasite Immunology.\" 29, \"GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.\" 445 (2007)","DOI":"10.1111\/j.1365-3024.2007.00961.x"},{"key":"73","doi-asserted-by":"crossref","unstructured":"E. Jongert, V. Melkebeek, S. De Craeye, et al. \"Vaccine.\" 26, \"An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs.\" 1025 (2008a)","DOI":"10.1016\/j.vaccine.2007.11.058"},{"key":"74","doi-asserted-by":"crossref","unstructured":"E. Jongert, D. Verhelst, M. Abady, et al. \"Vaccine.\" 26, \"Protective Th1 immune responses against chronic toxoplasmosis induced by a protein-protein vaccine combination but not by its DNA-protein counterpart.\" 5289 (2008b)","DOI":"10.1016\/j.vaccine.2008.07.032"},{"key":"75","doi-asserted-by":"crossref","unstructured":"B. F. C. Kafsack, J. D. O. Pena, I. Coppens, et al. \"Science.\" 323, \"Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells.\" 530 (2009)","DOI":"10.1126\/science.1165740"},{"key":"76","doi-asserted-by":"crossref","unstructured":"A. Khaminets, J. P. Hunn, S. K\u00f6nen-Waisman, et al. \"Cellular Microbiology.\" 12, \"Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole.\" 939 (2010)","DOI":"10.1111\/j.1462-5822.2010.01443.x"},{"key":"77","doi-asserted-by":"crossref","unstructured":"G. Labesse, M. Gelin, Y. Bessin, et al. \"Structure.\" 17, \"ROP2 from Toxoplasma gondii: A virulence factor with a protein-kinase fold and no enzymatic activity.\" 139 (2009)","DOI":"10.1016\/j.str.2008.11.005"},{"key":"78","doi-asserted-by":"crossref","unstructured":"R. Leyva, P. H\u00e9rion, R. Saavedra, \"Parasitology Research.\" 87, \"Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii.\" 70 (2001)","DOI":"10.1007\/s004360000296"},{"key":"79","doi-asserted-by":"crossref","unstructured":"B. Li, G. Oledzka, R. G. McFarlane, et al. \"Parasite Immunology.\" 32, \"Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.\" 671 (2010)","DOI":"10.1111\/j.1365-3024.2010.01228.x"},{"key":"80","doi-asserted-by":"crossref","unstructured":"J. Li, X. Huang, G. Zhang, et al. \"Veterinary Parasitology.\" 179, \"Immune response and protective efficacy against homologous challenge in BALB\/c mice vaccinated with DNA vaccine encoding Toxoplasma gondii actin depolymerizing factor gene.\" 1 (2011)","DOI":"10.1016\/j.vetpar.2011.03.003"},{"key":"81","doi-asserted-by":"crossref","unstructured":"X-Z. Li, L. Lv, X. Zhang, et al. \"Infection, Genetics and Evolution.\" 45, \"Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice.\" 447 (2016)","DOI":"10.1016\/j.meegid.2016.10.006"},{"key":"82","doi-asserted-by":"crossref","unstructured":"X.-Z. Li, X.-H. Wang, L.-J., Xia, et al. \"BMC Infectious Diseases.\" 15, \"Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.\" 114 (2015a)","DOI":"10.1186\/s12879-015-0815-1"},{"key":"83","doi-asserted-by":"crossref","unstructured":"Z.-Y. Li, J. Chen, J. Lu, et al. \"Genetics and molecular research: GMR.\" 14, \"Sequence variation in ROP8 gene among Toxoplasma gondii isolates from different hosts and geographical localities.\" 11403 (2015b)","DOI":"10.4238\/2015.September.25.8"},{"key":"84","doi-asserted-by":"crossref","unstructured":"Z.-Y. Li, J. Chen, E. Petersen, et al. \"Vaccine.\" 32, \"Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice.\" 3058 (2014)","DOI":"10.1016\/j.vaccine.2014.03.042"},{"key":"85","doi-asserted-by":"crossref","unstructured":"Z.-Y. Li, J. Lu, N.-Z. Zhang, et al. \"Korean Journal of Parasitology.\" 56, \"Immune responses induced by HSP60 DNA vaccine against Toxoplasma gondii infection in Kunming mice.\" 237 (2018a)","DOI":"10.3347\/kjp.2018.56.3.237"},{"key":"86","doi-asserted-by":"crossref","unstructured":"Z.-Y. Li, J. Lu, N.-Z. Zhang, et al. \"Parasite.\" 25, \"Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice.\" 37 (2018b)","DOI":"10.1051\/parasite\/2018040"},{"key":"87","doi-asserted-by":"crossref","unstructured":"M. M. Liu, Z. G. Yuan, G. H. Peng, et al. \"Parasitology Research.\" 106, \"Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis.\" 1079 (2010a)","DOI":"10.1007\/s00436-010-1742-0"},{"key":"88","doi-asserted-by":"crossref","unstructured":"Q. Liu, S. Gao, L. Jiang, et al. \"Microbes and Infection.\" 10, \"A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB\/c mice.\" 1355 (2008)","DOI":"10.1016\/j.micinf.2008.08.002"},{"key":"89","doi-asserted-by":"crossref","unstructured":"Q. Liu, L. Shang, H. Jin, et al. \"Research in Veterinary Science.\" 89, \"The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18.\" 93 (2010b)","DOI":"10.1016\/j.rvsc.2010.01.007"},{"key":"90","doi-asserted-by":"crossref","unstructured":"Q. Liu, L. D. Singla, H. Zhou, \"Human Vaccines & Immunotherapeutics.\" 8, \"Vaccines against Toxoplasma gondii: Status, challenges and future directions.\" 1305 (2012)","DOI":"10.4161\/hv.21006"},{"key":"91","doi-asserted-by":"crossref","unstructured":"Q. Liu, F. Wang, G. Wang, et al. \"Human Vaccines & Immunotherapeutics.\" 10, \"Toxoplasma gondii: Immune response and protective efficacy induced by ROP16\/ GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2.\" 184 (2014)","DOI":"10.4161\/hv.26703"},{"key":"92","doi-asserted-by":"crossref","unstructured":"S. Liu, L. Shi, Y. Cheng, et al. \"Parasitology Research.\" 105, \"Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice.\" 267 (2009)","DOI":"10.1007\/s00436-009-1393-1"},{"key":"93","doi-asserted-by":"crossref","unstructured":"Y. Liu, A. Cao, Y. Li, et al. \"BMC Infectious Diseases.\" 17, \"Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB\/c mice.\" 403 (2017)","DOI":"10.1186\/s12879-017-2507-5"},{"key":"94","doi-asserted-by":"crossref","unstructured":"E. V. Louren\u00e7o, E. S. Bernardes, N. M. Silva, et al. \"Microbes and Infection.\" 8, \"Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii.\" 1244 (2006)","DOI":"10.1016\/j.micinf.2005.11.013"},{"key":"96","doi-asserted-by":"crossref","unstructured":"G. Lu, A. Zhou, M. Meng, et al. \"BMC Infectious Diseases.\" 14, \"Alphagalactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.\" 3862 (2014)","DOI":"10.1186\/s12879-014-0706-x"},{"key":"97","doi-asserted-by":"crossref","unstructured":"G. Lu, J. Zhou, Y. H. Zhao, et al. \"Parasite Immunology.\" 40, \"DNA vaccine ROP29 from Toxoplasma gondii containing R848 enhances protective immunity in mice.\" e12578 (2018)","DOI":"10.1111\/pim.12578"},{"key":"98","doi-asserted-by":"crossref","unstructured":"G. Lu, J. Zhou, A. Zhou, et al. \"Parasitology International.\" 66, \"SAG5B and SAG5C combined vaccine protects mice against Toxoplasma gondii infection.\" 596 (2017)","DOI":"10.1016\/j.parint.2017.06.002"},{"key":"99","doi-asserted-by":"crossref","unstructured":"S. Maraghi, A. A. Ghadiri, M. Tavalla, et al. \"Biologicals.\" 62, \"Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB\/c mice.\" 39 (2019)","DOI":"10.1016\/j.biologicals.2019.10.002"},{"key":"100","doi-asserted-by":"crossref","unstructured":"V. Martin, A. Supanitsky, P. C. Echeverria, et al. \"Clinical and Diagnostic Laboratory Immunology.\" 11, \"Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.\" 704 (2004)","DOI":"10.1128\/CDLI.11.4.704-710.2004"},{"key":"101","doi-asserted-by":"crossref","unstructured":"S. A. Mavi, M. H. Modarressi, M. Mohebali, et al. \"Infection and Drug Resistance.\" 12, \"Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB\/c mice.\" 2519 (2019)","DOI":"10.2147\/IDR.S209270"},{"key":"103","doi-asserted-by":"crossref","unstructured":"M. M. McFarland, S. J. Zach, X. Wang, et al. \"Antimicrobial Agents and Chemotherapy.\" 60, \"Review of experimental compounds demonstrating anti-Toxoplasma activity.\" 7017 (2016)","DOI":"10.1128\/AAC.01176-16"},{"key":"104","doi-asserted-by":"crossref","unstructured":"M. Meissner, M. Reiss, N. Viebig, et al. \"Journal of Cell Science.\" 115, \"A family of transmembrane microneme proteins of Toxoplasma gondii contain EGF-like domains and function as escorters.\" 563 (2002)","DOI":"10.1242\/jcs.115.3.563"},{"key":"105","doi-asserted-by":"crossref","unstructured":"M. Meng, S. He, G. Zhao, et al. \"Parasites & Vectors.\" 5, \"Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB\/ c mice.\" 273 (2012)","DOI":"10.1186\/1756-3305-5-273"},{"key":"106","doi-asserted-by":"crossref","unstructured":"M. Meng, A. Zhou, G. Lu, et al. \"BMC Infectious Diseases.\" 13, \"DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB\/c mice.\" 494 (2013)","DOI":"10.1186\/1471-2334-13-494"},{"key":"107","doi-asserted-by":"crossref","unstructured":"M.-N. M\u00e9v\u00e9lec, D. Bout, B. Desolme, et al. \"Vaccine.\" 23, \"Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GMCSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.\" 4489 (2005)","DOI":"10.1016\/j.vaccine.2005.04.025"},{"key":"108","doi-asserted-by":"crossref","unstructured":"J. Min, D. Qu, C. Li, et al. \"Vaccine.\" 30, \"Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy.\" 5631 (2012)","DOI":"10.1016\/j.vaccine.2012.06.081"},{"key":"109","unstructured":"R. Naserifar, F. Ghaffarifar, A. Dalimi, et al. \"Iranian Journal of Parasitology.\" \"Evaluation of immunogenicity of cocktail DNA vaccine containing plasmids encoding complete GRA5, SAG1, and ROP2 antigens of Toxoplasma gondii in BALB\/C mice.\" 590 (2015)"},{"key":"110","doi-asserted-by":"crossref","unstructured":"A. J. Neville, S. J. Zach, X. Wang, et al. \"Antimicrobial Agents and Chemotherapy.\" 59, \"Clinically available medicines demonstrating anti-Toxoplasma activity.\" 7161 (2015)","DOI":"10.1128\/AAC.02009-15"},{"key":"111","doi-asserted-by":"crossref","unstructured":"H. V. Nielsen, M. Di Cristina, E. Beghetto, et al. \"Experimental Parasitology.\" 112, \"Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts.\" 274 (2006)","DOI":"10.1016\/j.exppara.2005.11.009"},{"key":"112","doi-asserted-by":"crossref","unstructured":"A. S. Pagheh, S. Sarvi, S. Gholami, et al. \"Microbial Pathogenesis.\" 134, \"Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.\" 103601 (2019)","DOI":"10.1016\/j.micpath.2019.103601"},{"key":"113","doi-asserted-by":"crossref","unstructured":"S. Parthasarathy, M. Y. Fong, K. Ramaswamy, et al. \"American Journal of Tropical Medicine and Hygiene.\" 88, \"Protective immune response in BALB\/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii.\" 883 (2013)","DOI":"10.4269\/ajtmh.12-0727"},{"key":"114","doi-asserted-by":"crossref","unstructured":"C. F. Pinzan, A. Sardinha-Silva, F. Almeida, et al. \"PLOS ONE.\" 10, \"Vaccination with recombinant microneme proteins confers protection against experimental toxoplasmosis in mice. Public Library of Science.\" e0143087 (2015)","DOI":"10.1371\/journal.pone.0143087"},{"key":"115","doi-asserted-by":"crossref","unstructured":"D. Qu, J. Han, A. Du, \"Parasitology Research.\" 112, \"Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice.\" 2593 (2013)","DOI":"10.1007\/s00436-013-3425-0"},{"key":"116","doi-asserted-by":"crossref","unstructured":"D. Qu, H. Yu, S. Wang, et al. \"Veterinary Parasitology.\" 166, \"Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.\" 220 (2009)","DOI":"10.1016\/j.vetpar.2009.08.016"},{"key":"117","doi-asserted-by":"crossref","unstructured":"J.-H. Quan, J.-Q. Chu, H. A. H. A. Ismail, et al. \"Clinical and Vaccine Immunology.\" 19, \"Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii.\" 666 (2012)","DOI":"10.1128\/CVI.05385-11"},{"key":"118","doi-asserted-by":"crossref","unstructured":"M. T. Rahimi, S. Sarvi, M. Sharif, et al. \"Parasitology Research.\" 116, \"Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB\/c mice.\" 609 (2017)","DOI":"10.1007\/s00436-016-5325-6"},{"key":"119","doi-asserted-by":"crossref","unstructured":"C. Ramakrishnan, S. Maier, R. A. Walker, et al. \"Scientific Reports.\" 9, \"An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats. Nature Publishing Group.\" 1474 (2019)","DOI":"10.1038\/s41598-018-37671-8"},{"key":"120","doi-asserted-by":"crossref","unstructured":"I. Rashid, D. Hedhli, N. Moir\u00e9, et al. \"Vaccine.\" 29, \"Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.\" 8838 (2011)","DOI":"10.1016\/j.vaccine.2011.09.099"},{"key":"121","doi-asserted-by":"crossref","unstructured":"I. Rashid, N. Moir\u00e9, B. H\u00e9raut, et al. \"Medical Microbiology and Immunology.\" 206, \"Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.\" 53 (2017)","DOI":"10.1007\/s00430-016-0483-9"},{"key":"122","doi-asserted-by":"crossref","unstructured":"M. Reiss, N. Viebig, S. Brecht, et al. \"Journal of Cell Biology.\" 152, \"Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondii.\" 563 (2001)","DOI":"10.1083\/jcb.152.3.563"},{"key":"123","doi-asserted-by":"crossref","unstructured":"M. Roozbehani, R. Falak, M. Mohammadi, et al. \"Vaccine.\" 36, \"Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.\" 6124 (2018)","DOI":"10.1016\/j.vaccine.2018.08.068"},{"key":"124","doi-asserted-by":"crossref","unstructured":"J. L. Roque-Res\u00e9ndiz, R. Rosales, P. Herion, \"Parasitology.\" 128, \"MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis.\" 397 (2004)","DOI":"10.1017\/S0031182003004761"},{"key":"125","doi-asserted-by":"crossref","unstructured":"C. Rosenberg, S. De Craeye, E. Jongert, et al. \"Vaccine.\" 27, \"Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens.\" 2489 (2009)","DOI":"10.1016\/j.vaccine.2009.02.058"},{"key":"126","doi-asserted-by":"crossref","unstructured":"D. L. Sacks, N. C. Peters, J. M. Bethony, \"The Vaccine Book.\" \"Vaccines against parasites.\" 331 (2016)","DOI":"10.1016\/B978-0-12-802174-3.00017-5"},{"key":"127","doi-asserted-by":"crossref","unstructured":"E. Scallan, R. M. Hoekstra, F. J. Angulo, et al. \"Emerging Infectious Diseases.\" 17, \"Foodborne illness acquired in the United States\u2014Major pathogens.\" 7 (2011)","DOI":"10.3201\/eid1701.P11101"},{"key":"128","doi-asserted-by":"crossref","unstructured":"T. Scorza, S. D'souza, M. Laloup, et al. \"Infection and Immunity.\" 71, \"A GRA1 DNA vaccine primes cytolytic CD8+ T cells to control acute Toxoplasma gondii infection.\" 309 (2003)","DOI":"10.1128\/IAI.71.1.309-316.2003"},{"key":"129","doi-asserted-by":"crossref","unstructured":"L. Shang, Q. Liu, W. Liu, et al. \"Vaccine.\" 27, \"Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge.\" 2741 (2009)","DOI":"10.1016\/j.vaccine.2009.03.013"},{"key":"130","doi-asserted-by":"crossref","unstructured":"D. J. Shedlock and D. B. Weiner \"Journal of Leukocyte Biology.\" 68, \"DNA vaccination: Antigen presentation and the induction of immunity.\" 793 (2000)","DOI":"10.1189\/jlb.68.6.793"},{"key":"131","unstructured":"T. R. F. Smith, A. Patel, S. Ramos, et al. \"Nature Communications.\" 11, \"Immunogenicity of a DNA vaccine candidate for COVID-19.\" 2601 (2020)"},{"key":"134","doi-asserted-by":"crossref","unstructured":"P. X. Song, S. H. Yao, Y. Yao, et al. \"Journal of Parasitology.\" 106, \"Epitope analysis and efficacy evaluation of phosphatase 2C (PP2C) DNA vaccine against Toxoplasma gondii infection.\" 513 (2020)","DOI":"10.1645\/18-210"},{"key":"135","doi-asserted-by":"crossref","unstructured":"H. Sun, J. Li, T. Xiao, et al. \"Microbial Pathogenesis.\" 147, \"Protective immunity induced by a DNA vaccine cocktail expressing TgSAG1, TgROP2, and the genetic adjuvant HBsAg against Toxoplasma gondii infection.\" 104441 (2020)","DOI":"10.1016\/j.micpath.2020.104441"},{"key":"136","doi-asserted-by":"crossref","unstructured":"X.-M. Sun, J. Zou, Aa Saeed, et al. \"Parasites & Vectors.\" 4, \"DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB\/c mice.\" 213 (2011)","DOI":"10.1186\/1756-3305-4-213"},{"key":"137","doi-asserted-by":"crossref","unstructured":"Q. Tao, R. Fang, W. Zhang, et al. \"Parasitology Research.\" 112, \"Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB\/c mice.\" 2871 (2013)","DOI":"10.1007\/s00436-013-3458-4"},{"key":"138","doi-asserted-by":"crossref","unstructured":"J. M. Turetzky, D. K. Chu, B. E. Hajagos, et al. \"International Journal for Parasitology.\" 40, \"Processing and secretion of ROP13: A unique Toxoplasma effector protein.\" 1037 (2010)","DOI":"10.1016\/j.ijpara.2010.02.014"},{"key":"139","doi-asserted-by":"crossref","unstructured":"M. Vercammen, T. Scorza, K. Huygen, et al. \"Infection and Immunity.\" 68, \"DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.\" 38 (2000)","DOI":"10.1128\/IAI.68.1.38-45.2000"},{"key":"140","doi-asserted-by":"crossref","unstructured":"R. Verma and P. Khanna \"Human Vaccines & Immunotherapeutics.\" 9, \"Development of Toxoplasma gondii vaccine.\" 291 (2013)","DOI":"10.4161\/hv.22474"},{"key":"141","doi-asserted-by":"crossref","unstructured":"H. Wang, S. He, Y. Yao, et al. \"Experimental Parasitology.\" 122, \"Toxoplasma gondii: Protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.\" 226 (2009)","DOI":"10.1016\/j.exppara.2009.04.002"},{"key":"142","doi-asserted-by":"crossref","unstructured":"H.-L. Wang, Y.-J. Wang, Y.-J. Pei, et al. \"Parasite.\" 23, \"DNA vaccination with a gene encoding Toxoplasma gondii rhoptry protein 17 induces partial protective immunity against lethal challenge in mice.\" 4 (2016a)","DOI":"10.1051\/parasite\/2016004"},{"key":"143","doi-asserted-by":"crossref","unstructured":"J.-L. Wang, N.-Z. Zhang, T.-T. Li, et al. \"Trends in Parasitology.\" 35, \"Advances in the development of anti-Toxoplasma gondii vaccines: Challenges, opportunities, and perspectives.\" 239 (2019)","DOI":"10.1016\/j.pt.2019.01.005"},{"key":"144","doi-asserted-by":"crossref","unstructured":"L. Wang, G. Lu, A. Zhou, et al. \"Parasite Immunology.\" 38, \"Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii.\" 209 (2016b)","DOI":"10.1111\/pim.12306"},{"key":"145","doi-asserted-by":"crossref","unstructured":"P.-Y. Wang, Z.-G. Yuan, E. Peterson, et al. \"Clinical and Vaccine Immunology.\" 19, \"Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice.\" 1916 (2012)","DOI":"10.1128\/CVI.00397-12"},{"key":"146","doi-asserted-by":"crossref","unstructured":"S. Wang, I. A. Hassan, X. Liu, et al. \"Research in Veterinary Science.\" 99, \"Immunological changes induced by Toxoplasma gondii glutathione-s-transferase (TgGST) delivered as a DNA vaccine.\" 157 (2015a)","DOI":"10.1016\/j.rvsc.2014.12.006"},{"key":"147","doi-asserted-by":"crossref","unstructured":"S. Wang, Y. Wang, X. Sun, et al. \"BMC Infectious Diseases.\" 15, \"Protective immunity against acute toxoplasmosis in BALB\/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.\" 448 (2015b)","DOI":"10.1186\/s12879-015-1220-5"},{"key":"148","doi-asserted-by":"crossref","unstructured":"S. Wang, Y. Wang, X. Sun, et al. \"Veterinary Parasitology.\" 214, \"Protective immunity against acute toxoplasmosis in BALB\/c mice induced by a DNA vaccine encoding Toxoplasma gondii 10kDa excretory\u2013secretory antigen (TgESA10).\" 40 (2015c)","DOI":"10.1016\/j.vetpar.2015.09.016"},{"key":"149","doi-asserted-by":"crossref","unstructured":"E. Watts, Y. Zhao, A. Dhara, et al. \"mBio.\" 6, \"Novel approaches reveal that Toxoplasma gondii bradyzoites within tissue cysts are dynamic and replicating entities in vivo.\" e01155 (2015)","DOI":"10.1128\/mBio.01155-15"},{"key":"150","unstructured":"Q. Wei, J. Li, T.-X. Fu, et al. \"Chinese Journal of Parasitology & Parasitic Diseases.\" 24, \"Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection].\" 337 (2006)"},{"key":"151","doi-asserted-by":"crossref","unstructured":"X.-N. Wu, J. Lin, X. Lin, et al. \"Parasitology Research.\" 111, \"Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: Anti-Toxoplasma immune response in mice.\" 2001 (2012)","DOI":"10.1007\/s00436-012-3047-y"},{"key":"152","doi-asserted-by":"crossref","unstructured":"X.-P. Xu, W.-G. Liu, Q.-M. Xu, et al. \"Parasite.\" 26, \"Evaluation of immune protection against Toxoplasma gondii infection in mice induced by a multi-antigenic DNA vaccine containing TgGRA24, TgGRA25 and TgMIC6.\" 58 (2019)","DOI":"10.1051\/parasite\/2019050"},{"key":"153","doi-asserted-by":"crossref","unstructured":"Y. Xu, N.-Z. Zhang, Q.-D. Tan, et al. \"BMC Infectious Diseases.\" 14, \"Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model.\" 525 (2014)","DOI":"10.1186\/1471-2334-14-525"},{"key":"154","doi-asserted-by":"crossref","unstructured":"M. Xue, S. He, Y. Cui, et al. \"Parasitology International.\" 57, \"Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.\" 424 (2008a)","DOI":"10.1016\/j.parint.2008.05.001"},{"key":"155","doi-asserted-by":"crossref","unstructured":"M. Xue, S. He, J. Zhang, et al. \"Experimental Parasitology.\" 119, \"Comparison of cholera toxin A2\/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine.\" 352 (2008b)","DOI":"10.1016\/j.exppara.2008.03.005"},{"key":"156","doi-asserted-by":"crossref","unstructured":"H.-K. Yan, Z.-G. Yuan, E. Petersen, et al. \"Experimental Parasitology.\" 128, \"Toxoplasma gondii: Protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1.\" 38 (2011)","DOI":"10.1016\/j.exppara.2011.02.005"},{"key":"157","doi-asserted-by":"crossref","unstructured":"H.-K. Yan, Z.-G. Yuan, H.-Q. Song, et al. \"Clinical and Vaccine Immunology.\" 19, \"Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii.\" 684 (2012)","DOI":"10.1128\/CVI.05578-11"},{"key":"158","unstructured":"T. Yang, S. He, H. Jiang, et al. \"Chinese Journal of Parasitology & Parasitic Diseases.\" 23, \"Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30].\" 14 (2005)"},{"key":"159","doi-asserted-by":"crossref","unstructured":"W.-B. Yang, D.-H. Zhou, Y. Zou, et al. \"Acta Tropica.\" 176, \"Vaccination with a DNA vaccine encoding Toxoplasma gondii ROP54 induces protective immunity against toxoplasmosis in mice.\" 427 (2017)","DOI":"10.1016\/j.actatropica.2017.09.007"},{"key":"160","doi-asserted-by":"crossref","unstructured":"R. H. D. Yba\u00f1ez, A. P. Yba\u00f1ez, Y. Nishikawa, \"Frontiers in Cellular and Infection Microbiology.\" 10, \"Review on the current trends of toxoplasmosis serodiagnosis in humans.\" 204 (2020)","DOI":"10.3389\/fcimb.2020.00204"},{"key":"161","doi-asserted-by":"crossref","unstructured":"H. Yin, L. Zhao, T. Wang, et al. \"Parasites & Vectors.\" 8, \"A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB\/c mice against parasite infection.\" 498 (2015)","DOI":"10.1186\/s13071-015-1108-7"},{"key":"162","unstructured":"J. Yu, L. H. Tostanoski, L. Peter, et al. \"Science.\" 369, \"DNA vaccine protection against SARS-CoV-2 in rhesus macaques.\" 806 (2020)"},{"key":"163","doi-asserted-by":"crossref","unstructured":"Z.-G. Yuan, D. Ren, D.-H. Zhou, et al. \"Vaccine.\" 31, \"Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model.\" 3135 (2013)","DOI":"10.1016\/j.vaccine.2013.05.040"},{"key":"164","doi-asserted-by":"crossref","unstructured":"Z.-G. Yuan, X.-X. Zhang, X.-H. He, et al. \"Clinical and Vaccine Immunology.\" 18, \"Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice.\" 119 (2011a)","DOI":"10.1128\/CVI.00312-10"},{"key":"165","doi-asserted-by":"crossref","unstructured":"Z.-G. Yuan, X.-X. Zhang, R.-Q. Lin, et al. \"Vaccine.\" 29, \"Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18.\" 6614 (2011b)","DOI":"10.1016\/j.vaccine.2011.06.110"},{"key":"166","doi-asserted-by":"crossref","unstructured":"G. Zhang, V. T. T. Huong, B. Battur, et al. \"Parasitology.\" 134, \"A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.\" 1339 (2007a)","DOI":"10.1017\/S0031182007002892"},{"key":"167","doi-asserted-by":"crossref","unstructured":"J. Zhang, S. He, H. Jiang, et al. \"Parasitology Research.\" 101, \"Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB\/c mice.\" 331 (2007b)","DOI":"10.1007\/s00436-007-0465-3"},{"key":"168","doi-asserted-by":"crossref","unstructured":"M. Zhang, L. Zhao, J. Song, et al. \"Vaccine.\" 31, \"DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB\/c mice against type II parasite infection.\" 4536 (2013a)","DOI":"10.1016\/j.vaccine.2013.07.065"},{"key":"169","doi-asserted-by":"crossref","unstructured":"N.-Z. Zhang, Q. Gao, M. Wang, et al. \"Frontiers in Immunology.\" 9, \"Immunization with a DNA vaccine cocktail encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 genes protects mice against chronic toxoplasmosis.\" 1505 (2018a)","DOI":"10.3389\/fimmu.2018.01505"},{"key":"170","doi-asserted-by":"crossref","unstructured":"N.-Z. Zhang, Q. Gao, M. Wang, et al. \"Frontiers in Microbiology.\" 9, \"Protective efficacy against acute and chronic Toxoplasma gondii infection induced by immunization with the DNA vaccine TgDOC2C.\" 2965 (2018b)","DOI":"10.3389\/fmicb.2018.02965"},{"key":"171","doi-asserted-by":"crossref","unstructured":"N.-Z. Zhang, S.-Y. Huang, Y. Xu, et al. \"Clinical and Vaccine Immunology.\" 21, \"Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5.\" 924 (2014)","DOI":"10.1128\/CVI.00059-14"},{"key":"172","doi-asserted-by":"crossref","unstructured":"N.-Z. Zhang, S.-Y. Huang, D.-H. Zhou, et al. \"BMC Infectious Diseases.\" 13, \"Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: Calcium-dependent protein kinase 3.\" 512 (2013b)","DOI":"10.1186\/1471-2334-13-512"},{"key":"173","doi-asserted-by":"crossref","unstructured":"Z. Zhang, Y. Li, Y. Liang, et al. \"Veterinary Parasitology.\" 260, \"Molecular characterization and protective immunity of rhoptry protein 35 (ROP35) of Toxoplasma gondii as a DNA vaccine.\" 12 (2018c)","DOI":"10.1016\/j.vetpar.2018.06.016"},{"key":"174","doi-asserted-by":"crossref","unstructured":"Z. Zhang, Y. Li, M. Wang, et al. \"Frontiers in Microbiology.\" 9, \"Immune protection of rhoptry protein 21 (ROP21) of Toxoplasma gondii as a DNA vaccine against toxoplasmosis.\" 909 (2018d)","DOI":"10.3389\/fmicb.2018.00909"},{"key":"175","doi-asserted-by":"crossref","unstructured":"Z. Zhang, Y. Li, Q. Xie, et al. \"Journal of Eukaryotic Microbiology.\" 66, \"The molecular characterization and immunity identification of rhoptry protein 22 of Toxoplasma gondii as a DNA vaccine candidate against toxoplasmosis.\" 147 (2019)","DOI":"10.1111\/jeu.12639"},{"key":"176","doi-asserted-by":"crossref","unstructured":"N.-Z. Zhang, Y. Xu, M. Wang, et al. \"Expert Review of Vaccines.\" 14, \"Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice.\" 1289 (2015)","DOI":"10.1586\/14760584.2015.1061938"},{"key":"177","doi-asserted-by":"crossref","unstructured":"G. Zhao, A. Zhou, G. Lu, et al. \"Parasites & Vectors.\" 6, \"Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis.\" 175 (2013a)","DOI":"10.1186\/1756-3305-6-175"},{"key":"178","doi-asserted-by":"crossref","unstructured":"G. Zhao, A. Zhou, G. Lu, et al. \"BMC Infectious Diseases.\" 13, \"Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis.\" 207 (2013b)","DOI":"10.1186\/1471-2334-13-207"},{"key":"179","doi-asserted-by":"crossref","unstructured":"Y. Zhao, Z.-Y. Li, J. Chen, et al. \"Experimental Parasitology.\" 163, \"Protective efficacy of pVAX-RON5p against acute and chronic infections of Toxoplasma gondii in BALB\/c mice.\" 24 (2016)","DOI":"10.1016\/j.exppara.2016.01.011"},{"key":"180","doi-asserted-by":"crossref","unstructured":"B. Zheng, J. Ding, X. Chen, et al. \"Frontiers in Microbiology.\" 8, \"Immuno-efficacy of a T. gondii secreted protein with an altered thrombospondin repeat (TgSPATR) as a novel DNA vaccine candidate against acute toxoplasmosis in BALB\/c mice.\" 216 (2017a)","DOI":"10.3389\/fmicb.2017.00216"},{"key":"181","doi-asserted-by":"crossref","unstructured":"B. Zheng, J. Ding, D. Lou, et al. \"Frontiers in Microbiology.\" 10, \"The virulence-related MYR1 protein of Toxoplasma gondii as a novel DNA vaccine against toxoplasmosis in mice.\" 734 (2019a)","DOI":"10.3389\/fmicb.2019.00734"},{"key":"182","doi-asserted-by":"crossref","unstructured":"B. Zheng, D. Lou, J. Ding, et al. \"Frontiers in Immunology.\" 10, \"GRA24-based DNA vaccine prolongs survival in mice challenged with a virulent Toxoplasma gondii strain.\" 418 (2019b)","DOI":"10.3389\/fimmu.2019.00418"},{"key":"183","doi-asserted-by":"crossref","unstructured":"L. Zheng, Y. Hu, Q. Hua, et al. \"Acta Tropica.\" 166, \"Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii.\" 336 (2017b)","DOI":"10.1016\/j.actatropica.2016.12.004"},{"key":"184","doi-asserted-by":"crossref","unstructured":"H. Zhou, J. Min, Q. Zhao, et al. \"Vaccine.\" 30, \"Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant.\" 1800 (2012)","DOI":"10.1016\/j.vaccine.2012.01.004"},{"key":"185","doi-asserted-by":"crossref","unstructured":"J. Zhou and L. Wang \"Frontiers in Microbiology.\" 8, \"SAG4 DNA and peptide vaccination provides partial protection against T. gondii infection in BALB\/c mice.\" 1733 (2017)","DOI":"10.3389\/fmicb.2017.01733"},{"key":"186","doi-asserted-by":"crossref","unstructured":"J. Zhou, L. Wang, G. Lu, et al. \"Parasite.\" 23, \"Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii.\" 17 (2016)","DOI":"10.1051\/parasite\/2016017"},{"key":"187","doi-asserted-by":"crossref","unstructured":"W.-N. Zhu, J.-L. Wang, K. Chen, et al. \"Experimental Parasitology.\" 179, \"Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.\" 20 (2017)","DOI":"10.1016\/j.exppara.2017.06.002"},{"key":"188","doi-asserted-by":"crossref","unstructured":"Y.-C. Zhu, Y. He, J.-F. Liu, et al. \"Parasite.\" 27, \"Adjuvantic cytokine IL-33 improves the protective immunity of cock-tailed DNA vaccine of ROP5 and ROP18 against Toxoplasma gondii infection in mice.\" 26 (2020)","DOI":"10.1051\/parasite\/2020021"},{"key":"189","doi-asserted-by":"crossref","unstructured":"S. Zimmermann, A. Dalpke, K. Heeg, \"International Journal of Medical Microbiology.\" 298, \"CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.\" 39 (2008)","DOI":"10.1016\/j.ijmm.2007.07.011"}],"container-title":["Journal of Parasitology"],"original-title":[],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T18:55:39Z","timestamp":1673895339000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/journal-of-parasitology\/volume-107\/issue-6\/20-157\/Review-of-DNA-Vaccine-Approaches-Against-the-Parasite-Toxoplasma-gondii\/10.1645\/20-157.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":189,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1645\/20-157","relation":{},"ISSN":["0022-3395"],"issn-type":[{"value":"0022-3395","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,30]]}}}